Although a 15-day course of Paxlovid was found to be safe, it didn’t demonstrate a significant benefit in improving symptoms.
Paxlovid fails to improve long COVID symptoms in small study
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows